MIC
GILD icon

Means Investment Company’s Gilead Sciences GILD Stock Holding History

Means Investment Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,800
Closed -$14K – 187
2020
Q3 		$14K Buy
+7,800
New +$541K ﹤0.01% 148

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Means Investment Company's GILD Position: Q1 2026 in Review

Means Investment Company increased its Gilead Sciences (GILD) stake by 0.1% in Q1 2026, buying an estimated $700 and bringing the position to 4,858 shares worth $677K. The position accounts for 0.06% of the portfolio, ranked #110.

Means Investment Company first reported a position in GILD in Q4 2018 and has held it in 30 quarters since. The position peaked at $698K in Q1 2020. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Means Investment Company held 4,858 shares of Gilead Sciences worth $677K as of Q1 2026.
  • Means Investment Company bought 5 Gilead Sciences shares in Q1 2026, an estimated $700.
  • Gilead Sciences made up 0.06% of Means Investment Company's portfolio in Q1 2026, its #110 holding.
  • Means Investment Company first reported a position in Gilead Sciences in Q4 2018 and has held it in 30 quarters since.
  • Means Investment Company's Gilead Sciences position peaked at $698K in Q1 2020.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Means Investment Company's 13F filing for Q1 2026, filed 24 Apr 2026.